HER2-Positive Breast Cancer
Sara Hurvitz · Kelly McCann
Jul 2018 · Elsevier Health Sciences
5.0star
2 reviewsreport
eBook
264
Pages
family_home
Eligible
info
reportRatings and reviews aren’t verified Learn more
About this eBook
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today's available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists. - Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive. - Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations. - Includes a timely section on innovative future therapies.
Ratings and reviews
5.0
2 reviews
Wim Bossenbroek
- Flag inappropriate
09 July 2021
Very useful and full of information about the evidence in HER2-positive breast cancer studies
Rate this eBook
Tell us what you think.
Reading information
Smartphones and tablets
Install the Google Play Books app for Android and iPad/iPhone. It syncs automatically with your account and allows you to read online or offline wherever you are.
Laptops and computers
You can listen to audiobooks purchased on Google Play using your computer's web browser.
eReaders and other devices
To read on e-ink devices like Kobo eReaders, you'll need to download a file and transfer it to your device. Follow the detailed Help Centre instructions to transfer the files to supported eReaders.
